✦ LIBER ✦

Biosimilar Granulocyte Colony-Stimulating Factor Uptakes in the EU-5 Markets: A Descriptive Analysis

✍ Scribed by Bocquet, François; Paubel, Pascal; Fusier, Isabelle; Cordonnier, Anne-Laure; Le Pen, Claude; Sinègre, Martine

Book ID: 121536141
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2014
Tongue: English
Weight: 390 KB
Volume: 12
Category: Article
ISSN: 1175-5652
DOI: 10.1007/s40258-014-0087-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

To What Extent Can Biosimilars Compete w

To What Extent Can Biosimilars Compete with Brand Name Biologics? A EU-5 Granulocyte-Colony Stimulating Factors Markets Analysis

✍ Bocquet, F.; Paubel, P.; Fusier, I.; Cordonnier, A.L.; Le Pen, C.; Sinègre, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PHP39 Explaning Differences in EU5 Marke

PHP39 Explaning Differences in EU5 Market Penetration Levels and Rates of Biosimilars: The Case of Epoetine, Granulocyte-Colony Stimulating Factor, and Growth Hormones

✍ A. Frenzel; N. Schmidt; J. Grahl 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Role of granulocyte and granulocyte-macr

Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis

✍ Berghmans, T; Paesmans, M; Lafitte, J.J; Mascaux, C; Meert, A.P; Sculier, J.P 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Hyperfractionated radiation therapy and

Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (± granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma

✍ André A. Abitbol; Kasi S. Sridhar; Alan A. Lewin; James G. Schwade; William Raub 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 3 views

initial entry of 34 patients. Cancer Center, University of Miami School of RESULTS. At a median follow-up of 41 months (range, 12-80 months), 44 patients Medicine, Miami, Florida. were alive with a projected median overall survival of 54 months. Grade 3/4 muco-2 Regional Cancer Center, Baptist Hosp

Phase II study of cisplatin as a 5-day c

Phase II study of cisplatin as a 5-day continuous infusion with vindesine plus recombinant human granulocyte-colony-stimulating factor in the treatment of advanced non-small-cell lung cancer

✍ Yoshikuni Saito; Kiyoshi Mori; Keigo Tominaga; Kouhei Yokoi; Naoto Miyazawa 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 500 KB

Expression of the human granulocyte–macr

Expression of the human granulocyte–macrophage colony stimulating factor (hGM-CSF) gene under control of the 5′-regulatory sequence of the goat alpha-S1-casein gene with and without a MAR element in transgenic mice

✍ I. A. Burkov, I. A. Serova, N. R. Battulin, A. V. Smirnov… 📂 Article 📅 2013 🏛 Springer Netherlands 🌐 English ⚖ 733 KB